URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Jane Liesveld

Concepts (582)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Leukemia, Myeloid, Acute
20
1988
183
4.500
Why?
Hematopoietic Stem Cells
19
1989
200
3.290
Why?
Bone Marrow Transplantation
18
1993
201
2.840
Why?
Stem Cell Transplantation
7
1993
115
2.430
Why?
Antigens, CD34
22
1989
52
2.320
Why?
Hematopoietic Stem Cell Transplantation
15
1998
133
2.290
Why?
Leukemia
12
1991
158
2.240
Why?
Antineoplastic Agents
13
1999
628
2.040
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
11
1993
56
1.970
Why?
Leukemia, Myeloid
9
1988
121
1.840
Why?
Antineoplastic Combined Chemotherapy Protocols
19
1993
436
1.820
Why?
Hematopoiesis
11
1986
129
1.660
Why?
Bone Marrow Cells
15
1989
222
1.610
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
10
1993
84
1.510
Why?
Myelodysplastic Syndromes
5
2001
132
1.370
Why?
Hematopoietic Stem Cell Mobilization
5
2000
15
1.250
Why?
Humans
111
1986
37165
1.230
Why?
Boronic Acids
4
2005
30
1.160
Why?
Pyrazines
4
2005
34
1.150
Why?
Apoptosis
9
1996
855
1.120
Why?
Lymphoma, Non-Hodgkin
8
1988
113
1.080
Why?
Heterocyclic Compounds
4
2004
15
1.040
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
1999
82
1.030
Why?
Transplantation, Homologous
14
1995
280
1.020
Why?
Adult
55
1988
11572
0.990
Why?
Hematopoietic Cell Growth Factors
7
1993
15
0.960
Why?
Stem Cells
5
1986
361
0.940
Why?
Middle Aged
47
1988
10013
0.920
Why?
Graft vs Host Disease
9
1999
95
0.920
Why?
Thrombocytopenia
3
1987
77
0.900
Why?
Antigens, CD
13
1991
254
0.880
Why?
Neoplastic Stem Cells
6
1994
40
0.880
Why?
Receptors, Thrombopoietin
1
2012
9
0.870
Why?
Hydrazines
1
2012
14
0.860
Why?
Cytokines
9
1988
575
0.860
Why?
Hodgkin Disease
6
1993
156
0.860
Why?
Leukemia, Promyelocytic, Acute
2
2006
33
0.860
Why?
Benzoates
1
2012
16
0.850
Why?
Pyrazoles
1
2012
59
0.830
Why?
Cell Survival
5
1989
559
0.830
Why?
Stromal Cells
4
1996
71
0.820
Why?
Granulocyte Colony-Stimulating Factor
6
1993
45
0.810
Why?
Protease Inhibitors
1
2011
42
0.800
Why?
Cell Adhesion
10
1988
270
0.790
Why?
Molecular Targeted Therapy
1
2010
20
0.770
Why?
Integrins
3
1993
48
0.750
Why?
Registries
2
2008
218
0.750
Why?
Female
54
1988
20222
0.730
Why?
Neoplasm Proteins
4
1994
190
0.730
Why?
Quinolones
3
2001
27
0.710
Why?
Transplantation, Autologous
13
1993
151
0.710
Why?
Cell Movement
4
2001
378
0.700
Why?
Aged
35
1988
7392
0.690
Why?
Transplantation Chimera
2
2005
28
0.690
Why?
Bone Marrow
12
1986
292
0.690
Why?
Cytarabine
8
1998
93
0.690
Why?
Tumor Cells, Cultured
12
1991
886
0.670
Why?
Chromosomes, Human, Y
1
2008
4
0.670
Why?
Transplantation Tolerance
1
2008
4
0.670
Why?
Graft vs Tumor Effect
1
2008
7
0.660
Why?
Graft Rejection
2
2005
144
0.650
Why?
Male
51
1988
20139
0.640
Why?
Pyrimidines
4
2007
66
0.620
Why?
Thrombocythemia, Essential
1
2007
6
0.610
Why?
Janus Kinase 2
1
2007
15
0.610
Why?
Peripheral Blood Stem Cell Transplantation
3
2002
21
0.600
Why?
Cell Communication
2
2000
140
0.580
Why?
Alkyl and Aryl Transferases
2
2001
12
0.570
Why?
Eosinophilia
3
1988
33
0.570
Why?
Methylprednisolone
2
1999
46
0.550
Why?
Treatment Outcome
16
1993
2671
0.550
Why?
Graft Survival
3
2000
151
0.540
Why?
Coculture Techniques
5
1996
91
0.520
Why?
Neoplasms
4
2002
743
0.520
Why?
Hydroxyquinolines
3
1993
9
0.520
Why?
Antiviral Agents
2
2002
170
0.520
Why?
Lymphoma
4
1993
163
0.500
Why?
Antibodies, Monoclonal, Murine-Derived
5
2009
132
0.500
Why?
Farnesyltranstransferase
4
2001
15
0.500
Why?
Colony-Forming Units Assay
7
1988
38
0.500
Why?
Imagery (Psychotherapy)
1
2003
3
0.480
Why?
Combined Modality Therapy
13
1991
491
0.480
Why?
Antigens, CD18
3
1991
23
0.480
Why?
Music Therapy
1
2003
4
0.480
Why?
Relaxation Therapy
1
2003
15
0.480
Why?
Prognosis
9
1993
1078
0.480
Why?
Enzyme Inhibitors
2
2001
441
0.480
Why?
Quercetin
1
2003
11
0.470
Why?
Cord Blood Stem Cell Transplantation
1
2003
5
0.460
Why?
Stem Cell Factor
5
1993
18
0.460
Why?
Piperazines
3
2007
76
0.450
Why?
Piperidines
1
2003
43
0.450
Why?
Mice, SCID
5
2003
171
0.450
Why?
Blood Donors
1
2003
28
0.450
Why?
Adolescent
19
1993
5044
0.440
Why?
Acute Disease
9
1996
591
0.440
Why?
Flavonoids
1
2003
70
0.440
Why?
Endothelial Cells
1
2005
211
0.440
Why?
Cell Separation
4
1994
230
0.440
Why?
Disease-Free Survival
11
1995
204
0.430
Why?
Mice, Inbred NOD
4
2003
37
0.430
Why?
Survival Analysis
11
1993
589
0.430
Why?
Time Factors
10
1991
3234
0.430
Why?
Valine
1
2002
32
0.420
Why?
Acyclovir
1
2002
42
0.420
Why?
Growth Substances
3
1996
103
0.420
Why?
Multiple Myeloma
3
2004
75
0.410
Why?
Herpes Simplex
1
2002
47
0.410
Why?
Transforming Growth Factor beta
3
1993
411
0.400
Why?
Antibodies, Monoclonal
9
1986
748
0.400
Why?
Cell Differentiation
7
1991
1127
0.400
Why?
Macrophage Inflammatory Proteins
1
2000
25
0.380
Why?
Retrospective Studies
13
1991
2302
0.380
Why?
Survival Rate
12
1991
619
0.380
Why?
Chemokines
1
2001
112
0.380
Why?
Stomatitis
2
1999
16
0.380
Why?
Cell Cycle
4
1994
253
0.370
Why?
Nifedipine
1
1999
33
0.360
Why?
Parenteral Nutrition
1
1999
24
0.360
Why?
Remission Induction
9
1996
165
0.360
Why?
Receptors, Fc
2
1988
70
0.360
Why?
Lymphoma, Large B-Cell, Diffuse
2
2009
80
0.350
Why?
Cell Line, Tumor
4
2005
576
0.350
Why?
Drug Resistance, Neoplasm
3
1996
56
0.350
Why?
Methotrexate
1
1999
73
0.350
Why?
Mouth Mucosa
1
1999
44
0.350
Why?
Tissue Preservation
1
1999
20
0.350
Why?
Cyclosporine
1
1999
66
0.350
Why?
Neoplasm Recurrence, Local
3
2009
295
0.340
Why?
Calcium Channel Blockers
1
1999
69
0.340
Why?
Immunosuppressive Agents
2
1999
206
0.340
Why?
Lymphoma, Follicular
2
1991
61
0.340
Why?
Child
12
1995
4342
0.340
Why?
Recurrence
10
1993
697
0.340
Why?
Immunotherapy
2
1994
88
0.330
Why?
Amifostine
2
2004
28
0.320
Why?
Parvoviridae Infections
2
1993
12
0.310
Why?
Nuclear Proteins
2
1994
335
0.310
Why?
Child, Preschool
9
1997
2737
0.310
Why?
Phenotype
4
1989
756
0.310
Why?
Cell Adhesion Molecules
2
1994
73
0.300
Why?
Interleukin-1
4
1988
221
0.300
Why?
Antilymphocyte Serum
3
2005
26
0.300
Why?
Vidarabine
2
2005
28
0.300
Why?
Interleukin-3
4
1991
43
0.290
Why?
Nitric Oxide
1
1999
255
0.290
Why?
Leukemia, Megakaryoblastic, Acute
1
1996
10
0.290
Why?
B-Lymphocytes
3
1990
479
0.290
Why?
Cells, Cultured
7
1989
2589
0.280
Why?
Drug Resistance, Multiple
1
1996
30
0.280
Why?
Etoposide
4
1998
83
0.280
Why?
ABO Blood-Group System
3
2003
66
0.280
Why?
Dendritic Cells
2
2002
117
0.280
Why?
Mice
9
1995
6206
0.270
Why?
Neutrophils
1
1998
313
0.270
Why?
Oxygen
1
1999
495
0.270
Why?
Tretinoin
1
2006
104
0.270
Why?
Platelet Transfusion
2
2005
86
0.270
Why?
Databases, Factual
2
1999
159
0.260
Why?
Cell Proliferation
2
2007
520
0.260
Why?
Endothelium, Vascular
2
1994
454
0.260
Why?
Follow-Up Studies
5
1997
1889
0.260
Why?
Carmustine
3
1998
37
0.260
Why?
Extracellular Matrix
3
1989
170
0.250
Why?
Flow Cytometry
7
1990
603
0.250
Why?
Tumor Necrosis Factor-alpha
5
1993
694
0.240
Why?
Cell Division
4
1996
773
0.240
Why?
E-Selectin
2
1994
18
0.240
Why?
Animals
13
1992
16416
0.240
Why?
Macrophages
2
1991
347
0.240
Why?
Giant Cells
1
1993
12
0.240
Why?
Gene Expression Regulation, Neoplastic
1
2006
266
0.240
Why?
Antigens, Differentiation
2
1989
72
0.240
Why?
Histiocytoma, Benign Fibrous
1
1993
23
0.240
Why?
Transplantation Conditioning
2
2010
36
0.230
Why?
Antigens, Neoplasm
1
1994
109
0.230
Why?
Dose-Response Relationship, Drug
7
2000
1142
0.230
Why?
AIDS-Related Complex
1
1993
14
0.230
Why?
Blast Crisis
3
2006
19
0.230
Why?
Parvovirus B19, Human
1
1993
6
0.230
Why?
Erythroid Precursor Cells
1
1993
11
0.230
Why?
Caspase 3
2
2003
91
0.230
Why?
Red-Cell Aplasia, Pure
1
1993
9
0.230
Why?
Receptors, CXCR4
2
2001
26
0.230
Why?
Granulocytes
2
1989
83
0.230
Why?
Hematologic Neoplasms
3
1999
34
0.220
Why?
Infant
6
1999
2320
0.220
Why?
Caspases
2
2003
105
0.220
Why?
Cytoprotection
2
2004
40
0.220
Why?
Erythropoiesis
2
1987
63
0.220
Why?
Platelet Count
1
2012
52
0.210
Why?
Glucocorticoids
2
1987
168
0.210
Why?
Colony-Stimulating Factors
2
1988
27
0.210
Why?
Antibodies
3
1993
220
0.210
Why?
Antibody-Dependent Cell Cytotoxicity
2
1986
28
0.210
Why?
Fatal Outcome
1
2012
109
0.210
Why?
Abnormal Karyotype
1
2011
1
0.210
Why?
Benzenesulfonates
1
2011
8
0.210
Why?
Arsenicals
1
2011
7
0.210
Why?
Azacitidine
1
2011
18
0.200
Why?
Oxides
1
2011
23
0.200
Why?
Chromosomes, Human, Pair 5
1
2011
10
0.200
Why?
Thalidomide
1
2011
14
0.200
Why?
Gastrointestinal Tract
1
2011
26
0.200
Why?
Lambert-Eaton Myasthenic Syndrome
1
1991
3
0.200
Why?
Adverse Drug Reaction Reporting Systems
1
2010
7
0.200
Why?
Antigens, CD11
2
1991
3
0.200
Why?
Case-Control Studies
2
2003
624
0.200
Why?
P-Selectin
2
2007
23
0.200
Why?
Chromosome Deletion
1
2011
66
0.200
Why?
Nitrogen Mustard Compounds
1
2011
20
0.190
Why?
Pyridines
1
2011
85
0.190
Why?
Sesquiterpenes
2
2007
26
0.190
Why?
Lymphoma, Mantle-Cell
1
2011
21
0.190
Why?
Cohort Studies
5
2001
984
0.190
Why?
Culture Media
2
1988
196
0.180
Why?
Bone Marrow Diseases
2
1995
44
0.180
Why?
Recombinant Proteins
5
1988
770
0.180
Why?
Melphalan
2
2004
28
0.180
Why?
Kinetics
3
1991
1471
0.180
Why?
Biomimetic Materials
1
2009
3
0.180
Why?
Toll-Like Receptor 9
1
2009
12
0.180
Why?
T-Lymphocyte Subsets
2
1994
109
0.180
Why?
Blood Component Removal
1
2009
11
0.170
Why?
Lymphocytosis
1
2009
14
0.170
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2009
16
0.170
Why?
Interleukin-7
3
1994
10
0.170
Why?
Blood Cell Count
3
1987
45
0.170
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
1991
132
0.170
Why?
Analysis of Variance
3
1999
749
0.170
Why?
Erythrocyte Transfusion
2
2005
58
0.170
Why?
Genetic Diseases, Inborn
1
2008
17
0.170
Why?
Pilot Projects
3
2001
446
0.160
Why?
Immunophenotyping
4
1993
126
0.160
Why?
Skin Neoplasms
1
2011
230
0.160
Why?
Thiazoles
1
2009
93
0.160
Why?
Pelger-Huet Anomaly
1
1988
1
0.160
Why?
Killer Cells, Natural
1
2009
124
0.160
Why?
Protein Kinase Inhibitors
1
2009
97
0.160
Why?
Hydrocortisone
1
1988
133
0.160
Why?
T-Lymphocytes, Cytotoxic
1
2009
147
0.160
Why?
Biological Agents
1
1988
21
0.160
Why?
Soft Tissue Neoplasms
1
2008
46
0.160
Why?
Karyotyping
3
2006
112
0.160
Why?
Whole-Body Irradiation
4
1995
87
0.160
Why?
Thiadiazoles
1
2007
12
0.160
Why?
Sarcoma
1
2008
64
0.160
Why?
DNA Mutational Analysis
1
2008
192
0.160
Why?
Interleukin-2
1
1988
203
0.150
Why?
Translocation, Genetic
1
2007
65
0.150
Why?
Philadelphia Chromosome
1
2007
11
0.150
Why?
Chemokine CXCL12
1
2007
35
0.150
Why?
Anemia, Hemolytic, Autoimmune
1
1987
22
0.150
Why?
Predictive Value of Tests
3
1993
609
0.150
Why?
Skin Diseases
1
2008
121
0.150
Why?
Reticulocytes
1
1987
47
0.150
Why?
Amnesia, Anterograde
1
2006
1
0.150
Why?
HIV-1
1
1993
593
0.150
Why?
Cyclophosphamide
3
1998
177
0.140
Why?
Central Nervous System Depressants
1
2006
10
0.140
Why?
Adjuvants, Immunologic
2
1993
118
0.140
Why?
Liver
1
2011
884
0.140
Why?
Neoplasms, Second Primary
1
2008
125
0.140
Why?
Point Mutation
1
2007
178
0.140
Why?
Obesity
1
2010
349
0.140
Why?
Phosphorylation
2
2001
839
0.140
Why?
Fibroblasts
4
1986
545
0.140
Why?
Ethanol
1
2006
93
0.130
Why?
Plasma Cells
1
2005
26
0.130
Why?
Gene Expression Profiling
1
2008
304
0.130
Why?
Thalassemia
1
2005
23
0.130
Why?
Young Adult
4
2009
1084
0.130
Why?
Hispanic Americans
1
2005
105
0.130
Why?
Anemia, Sickle Cell
1
2005
48
0.130
Why?
Mutation
2
2001
1226
0.120
Why?
Radiotherapy, Adjuvant
2
1998
74
0.120
Why?
Drug Therapy, Combination
2
1999
397
0.120
Why?
Ethnic Groups
1
2005
160
0.120
Why?
Calcium
2
2000
1135
0.120
Why?
Hemorrhage
1
2005
181
0.120
Why?
Enzyme Activation
2
2001
611
0.120
Why?
Histocompatibility
1
2003
14
0.120
Why?
Annexin A5
1
2003
18
0.120
Why?
RNA, Messenger
3
1992
1893
0.120
Why?
Decision Support Techniques
1
2004
75
0.120
Why?
Poly(ADP-ribose) Polymerases
1
2003
59
0.120
Why?
Histocompatibility Testing
3
2005
38
0.110
Why?
Gene Expression Regulation, Leukemic
2
1997
19
0.110
Why?
Blood Group Incompatibility
1
2003
37
0.110
Why?
Transplantation Immunology
1
2003
18
0.110
Why?
Cell Line
3
1988
1623
0.110
Why?
Feasibility Studies
1
2003
212
0.110
Why?
Severity of Illness Index
3
1993
943
0.110
Why?
Vomiting
1
2003
116
0.110
Why?
Interferon-gamma
2
1999
341
0.110
Why?
Fetal Blood
1
2003
89
0.110
Why?
Cell Culture Techniques
1
2003
94
0.110
Why?
Leukocyte Count
2
1988
162
0.110
Why?
S Phase
2
1999
46
0.110
Why?
Cell Death
3
2005
175
0.110
Why?
Pancytopenia
3
2001
14
0.110
Why?
Interleukins
2
1991
64
0.110
Why?
Chronic Disease
3
1993
554
0.110
Why?
Nausea
1
2003
155
0.100
Why?
Pain Measurement
1
2003
248
0.100
Why?
Chemokines, CX3C
1
2001
9
0.100
Why?
Prospective Studies
3
1993
1696
0.100
Why?
Injections, Intravenous
1
2002
133
0.100
Why?
Leukopenia
2
1987
26
0.100
Why?
Chemokines, CC
1
2001
29
0.100
Why?
Chemokines, CXC
1
2001
45
0.100
Why?
Syndrome
2
1991
209
0.100
Why?
Administration, Oral
1
2002
314
0.100
Why?
Sweat Gland Diseases
1
2000
2
0.100
Why?
Interleukin-8
1
2001
111
0.100
Why?
Chemokine CCL4
1
2000
23
0.100
Why?
Chemokine CCL3
1
2000
19
0.100
Why?
Blood Grouping and Crossmatching
3
2000
32
0.100
Why?
T-Lymphocytes
3
1991
564
0.100
Why?
Oxidative Stress
2
1999
347
0.090
Why?
Salvage Therapy
2
2009
62
0.090
Why?
Regression Analysis
1
2002
539
0.090
Why?
Pentoxifylline
1
2000
27
0.090
Why?
Lymphocyte Activation
2
1997
414
0.090
Why?
Pain
1
2003
392
0.090
Why?
Kaplan-Meier Estimate
2
2010
207
0.090
Why?
Tissue Donors
3
2000
70
0.090
Why?
Anemia, Aplastic
1
1999
24
0.090
Why?
HLA Antigens
3
2000
98
0.090
Why?
Wiskott-Aldrich Syndrome
1
1999
9
0.090
Why?
Life Tables
1
1999
38
0.090
Why?
Diarrhea
1
1999
65
0.090
Why?
Penicillamine
1
1999
26
0.090
Why?
Partial Pressure
1
1999
56
0.090
Why?
Nitrites
1
1999
34
0.090
Why?
Corynebacterium Infections
1
1998
7
0.090
Why?
Receptor Protein-Tyrosine Kinases
2
1995
81
0.090
Why?
Proto-Oncogene Proteins c-kit
2
1995
14
0.080
Why?
Infectious Mononucleosis
1
1998
21
0.080
Why?
Nitric Oxide Synthase Type II
1
1999
58
0.080
Why?
Enzyme Induction
1
1999
155
0.080
Why?
Cause of Death
1
1999
158
0.080
Why?
Polymerase Chain Reaction
2
1993
597
0.080
Why?
Lysine
1
1999
75
0.080
Why?
HL-60 Cells
2
2007
50
0.080
Why?
Leukocyte Rolling
2
2007
17
0.080
Why?
Chemotaxis
1
1998
35
0.080
Why?
Neutropenia
1
1999
70
0.080
Why?
Nitric Oxide Synthase
1
1999
163
0.080
Why?
Receptors, Erythropoietin
1
1997
5
0.080
Why?
Leukocytes, Mononuclear
2
2007
112
0.080
Why?
Phagocytosis
1
1998
86
0.080
Why?
Patient Selection
1
1999
223
0.080
Why?
Lipopolysaccharides
1
1999
211
0.080
Why?
Monocytes
2
1988
317
0.080
Why?
Aged, 80 and over
3
2006
2588
0.080
Why?
Globins
1
1997
49
0.080
Why?
Yolk Sac
1
1997
57
0.080
Why?
Receptors, Interleukin
1
1997
10
0.080
Why?
Proto-Oncogene Proteins
2
1995
301
0.070
Why?
L-Selectin
1
1997
15
0.070
Why?
Reference Values
2
1991
453
0.070
Why?
Connective Tissue
1
1997
45
0.070
Why?
Actins
1
1998
214
0.070
Why?
Proteoglycans
1
1997
104
0.070
Why?
Bucladesine
1
1996
44
0.070
Why?
Embryo, Mammalian
1
1997
195
0.070
Why?
Reactive Oxygen Species
1
1999
317
0.070
Why?
Myeloablative Agonists
2
2000
6
0.070
Why?
Erythropoietin
1
1996
27
0.070
Why?
Extracellular Matrix Proteins
1
1997
76
0.070
Why?
B-Lymphocyte Subsets
1
1997
68
0.070
Why?
RNA
1
2000
413
0.070
Why?
DNA, Neoplasm
1
1996
129
0.070
Why?
Microscopy, Electron
1
1996
395
0.070
Why?
Receptors, Colony-Stimulating Factor
1
1995
1
0.070
Why?
Actuarial Analysis
2
1991
21
0.060
Why?
Drug Administration Schedule
2
2003
374
0.060
Why?
Chromosome Aberrations
2
2003
117
0.060
Why?
Vascular Cell Adhesion Molecule-1
1
1994
45
0.060
Why?
Umbilical Veins
1
1994
80
0.060
Why?
Leukemia, Experimental
1
1994
22
0.060
Why?
Ki-67 Antigen
1
1994
29
0.060
Why?
Treatment Failure
2
2001
131
0.060
Why?
Gene Expression Regulation
1
2000
895
0.060
Why?
In Situ Hybridization, Fluorescence
2
2002
114
0.060
Why?
Anemia
1
1994
78
0.060
Why?
Interleukin-4
2
1991
160
0.060
Why?
Rabbits
2
2005
720
0.060
Why?
Macrophage Colony-Stimulating Factor
1
1993
25
0.060
Why?
Neoplasm Invasiveness
1
1994
160
0.060
Why?
Intercellular Adhesion Molecule-1
1
1994
119
0.060
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2000
93
0.060
Why?
Recombinant Fusion Proteins
2
2002
392
0.060
Why?
Leukemia, Monocytic, Acute
1
1993
12
0.060
Why?
Lymphocytes
1
1994
298
0.060
Why?
Tetradecanoylphorbol Acetate
1
1993
161
0.060
Why?
Clinical Trials as Topic
1
1997
685
0.060
Why?
Platelet-Derived Growth Factor
1
1993
114
0.060
Why?
Immunoglobulins, Intravenous
1
1993
37
0.060
Why?
Up-Regulation
1
1994
375
0.050
Why?
Infection
2
2000
67
0.050
Why?
Megakaryocytes
1
1993
67
0.050
Why?
Dexamethasone
1
1993
188
0.050
Why?
Risk Factors
3
2003
2331
0.050
Why?
Sea Urchins
1
1992
19
0.050
Why?
Aniline Compounds
1
1992
25
0.050
Why?
Dogs
2
1995
492
0.050
Why?
Cell Count
2
2002
287
0.050
Why?
Injections, Intra-Arterial
1
2011
31
0.050
Why?
Leukemia, Myelomonocytic, Chronic
2
2001
20
0.050
Why?
Ribosomal Proteins
1
1992
38
0.050
Why?
Cytotoxicity Tests, Immunologic
1
1991
30
0.050
Why?
RNA, Ribosomal
1
1992
67
0.050
Why?
Disease Outbreaks
1
1992
115
0.050
Why?
Maximum Tolerated Dose
1
2010
18
0.050
Why?
Mucositis
1
2010
14
0.050
Why?
Neutralization Tests
1
1991
128
0.050
Why?
Drug Resistance
1
2011
100
0.050
Why?
Plastics
1
1990
13
0.050
Why?
Proportional Hazards Models
2
1993
426
0.050
Why?
Cell Transformation, Neoplastic
1
2011
138
0.050
Why?
Medical Records
1
2011
140
0.050
Why?
Thinness
1
2010
11
0.050
Why?
Nuclear Family
2
2000
13
0.050
Why?
Electrophysiology
1
1991
249
0.050
Why?
Antigens, Differentiation, B-Lymphocyte
1
1990
51
0.050
Why?
Overweight
1
2010
42
0.050
Why?
Vincristine
1
2009
61
0.040
Why?
Gene Expression
1
1993
764
0.040
Why?
Chemokine CXCL10
1
2009
24
0.040
Why?
Immobilized Proteins
1
2009
1
0.040
Why?
Chi-Square Distribution
1
1991
347
0.040
Why?
Pleurisy
1
2009
2
0.040
Why?
Clinical Trials, Phase II as Topic
1
2009
14
0.040
Why?
Cell Compartmentation
1
1989
57
0.040
Why?
Atrial Fibrillation
1
2010
112
0.040
Why?
Lymphoma, B-Cell, Marginal Zone
1
2009
10
0.040
Why?
Colitis
1
2009
26
0.040
Why?
Doxorubicin
1
2009
105
0.040
Why?
Lymphoproliferative Disorders
1
2009
30
0.040
Why?
Fibronectins
1
1990
151
0.040
Why?
Eosinophils
1
1988
46
0.040
Why?
Oligodeoxyribonucleotides
1
2009
141
0.040
Why?
Surface Properties
1
2009
170
0.040
Why?
Cladribine
1
2008
7
0.040
Why?
Prednisone
1
2009
182
0.040
Why?
Multicenter Studies as Topic
1
2009
127
0.040
Why?
Biopsy, Fine-Needle
1
2008
20
0.040
Why?
Triterpenes
1
2008
1
0.040
Why?
Binding Sites, Antibody
1
1988
34
0.040
Why?
Neoadjuvant Therapy
1
2008
32
0.040
Why?
Terpenes
1
2008
16
0.040
Why?
HIV Infections
1
1994
616
0.040
Why?
Data Interpretation, Statistical
1
2009
157
0.040
Why?
Comorbidity
1
2010
377
0.040
Why?
Deoxycytidine
1
2008
28
0.040
Why?
Cysteine Proteinase Inhibitors
1
2008
28
0.040
Why?
Diagnosis, Differential
1
2011
889
0.040
Why?
Chemotherapy, Adjuvant
1
2008
88
0.040
Why?
Chemokine CCL2
1
2009
128
0.040
Why?
Cycloheximide
1
1988
88
0.040
Why?
Chromosomes, Human, Pair 8
1
2007
16
0.040
Why?
Databases, Genetic
1
2008
25
0.040
Why?
Aldehydes
1
2008
27
0.040
Why?
Neoplasm Metastasis
1
2009
229
0.040
Why?
Chromosomes, Human, Pair 21
1
2007
13
0.040
Why?
Xenograft Model Antitumor Assays
1
2008
46
0.040
Why?
Proteasome Endopeptidase Complex
1
2008
70
0.040
Why?
Saccharomyces cerevisiae Proteins
1
1992
256
0.040
Why?
Siblings
1
2007
36
0.040
Why?
fms-Like Tyrosine Kinase 3
1
2007
4
0.040
Why?
Antigens, Human Platelet
1
2007
8
0.040
Why?
Biological Availability
1
2007
38
0.040
Why?
Leukocyte Reduction Procedures
1
2007
13
0.040
Why?
Receptors, IgG
1
1988
74
0.040
Why?
Exons
1
2008
170
0.040
Why?
Culture Media, Conditioned
1
2007
66
0.040
Why?
Drug Design
1
2007
45
0.040
Why?
Physician's Practice Patterns
1
1991
268
0.040
Why?
Thrombocytosis
1
1987
5
0.040
Why?
Chromosome Banding
1
2007
28
0.040
Why?
Models, Genetic
1
2008
162
0.040
Why?
Centromere
1
2007
11
0.040
Why?
Sulfhydryl Compounds
1
2007
75
0.040
Why?
Leukocytosis
1
1987
21
0.040
Why?
HSP40 Heat-Shock Proteins
1
2006
6
0.040
Why?
Hematocrit
1
1987
111
0.040
Why?
Endothelium
1
1986
60
0.040
Why?
Tumor Markers, Biological
1
2009
240
0.040
Why?
Forensic Medicine
1
2006
7
0.040
Why?
Drinking Behavior
1
2006
9
0.040
Why?
Structure-Activity Relationship
1
2007
316
0.040
Why?
Data Collection
1
2007
231
0.040
Why?
Tumor Suppressor Protein p53
1
2007
140
0.040
Why?
DNA Nucleotidylexotransferase
2
1994
15
0.030
Why?
Oligonucleotide Array Sequence Analysis
1
2008
290
0.030
Why?
Proteins
1
2009
470
0.030
Why?
Antibodies, Neoplasm
1
2005
41
0.030
Why?
Postoperative Complications
1
2010
764
0.030
Why?
Risk
1
2006
355
0.030
Why?
Immunohistochemistry
1
2009
1082
0.030
Why?
Immunoglobulin Fab Fragments
1
2005
31
0.030
Why?
Minority Groups
1
2005
59
0.030
Why?
Immunoglobulin G
1
2007
494
0.030
Why?
Hemoglobinopathies
1
2005
8
0.030
Why?
Protein Kinase C
1
2007
259
0.030
Why?
Cell Membrane
1
2007
506
0.030
Why?
Drug Synergism
1
2005
163
0.030
Why?
Sensitivity and Specificity
1
2008
914
0.030
Why?
Reproducibility of Results
1
2008
903
0.030
Why?
Radiation-Protective Agents
1
2004
41
0.030
Why?
Markov Chains
1
2004
40
0.030
Why?
Gene Expression Regulation, Developmental
2
1997
358
0.030
Why?
Cytogenetics
1
2003
15
0.030
Why?
Tomography, X-Ray Computed
1
2008
785
0.030
Why?
Logistic Models
1
2006
626
0.030
Why?
Blood Transfusion
1
2005
171
0.030
Why?
NF-kappa B
1
2007
434
0.030
Why?
Statistics, Nonparametric
1
2004
269
0.030
Why?
Microscopy, Phase-Contrast
1
2002
17
0.030
Why?
Vascular Endothelial Growth Factor Receptor-1
1
2002
11
0.030
Why?
Odds Ratio
1
2003
323
0.030
Why?
Protein Prenylation
1
2001
4
0.030
Why?
Genes, ras
1
2001
34
0.030
Why?
Mitoxantrone
1
2001
20
0.020
Why?
Anemia, Refractory, with Excess of Blasts
1
2001
9
0.020
Why?
Hyperbilirubinemia
1
2001
13
0.020
Why?
Disease Progression
1
2003
533
0.020
Why?
Drug-Induced Liver Injury
1
2001
36
0.020
Why?
Mitogen-Activated Protein Kinase 3
1
2001
106
0.020
Why?
Questionnaires
1
2006
1061
0.020
Why?
Randomized Controlled Trials as Topic
1
2003
415
0.020
Why?
Graft vs Leukemia Effect
1
2000
8
0.020
Why?
Mitogen-Activated Protein Kinase 1
1
2001
106
0.020
Why?
Necrosis
1
2000
103
0.020
Why?
Infant, Newborn
1
2005
1836
0.020
Why?
Drug Toxicity
1
2000
17
0.020
Why?
Drug Evaluation
1
2000
99
0.020
Why?
Evaluation Studies as Topic
1
2000
247
0.020
Why?
Placebos
1
2000
185
0.020
Why?
Mitogen-Activated Protein Kinases
1
2001
215
0.020
Why?
DNA Replication
1
2001
207
0.020
Why?
Bone Marrow Examination
1
1998
25
0.020
Why?
Behavior Therapy
1
2000
110
0.020
Why?
Base Sequence
2
1992
1721
0.020
Why?
Signal Transduction
1
2007
1629
0.020
Why?
Mice, Inbred ICR
1
1997
82
0.020
Why?
Molecular Sequence Data
2
1992
2046
0.020
Why?
Oligonucleotides, Antisense
1
1997
55
0.020
Why?
Organ Culture Techniques
1
1997
99
0.020
Why?
Erythroblasts
1
1997
38
0.020
Why?
Neoplasm, Residual
1
1997
21
0.020
Why?
Embryonic and Fetal Development
1
1997
95
0.020
Why?
Receptors, Interleukin-7
1
1997
4
0.020
Why?
Antigens, CD19
1
1997
13
0.020
Why?
Antigens, CD45
1
1997
38
0.020
Why?
Double-Blind Method
1
2000
996
0.020
Why?
United States
1
2005
2847
0.020
Why?
Clone Cells
1
1997
188
0.020
Why?
Multivariate Analysis
1
1997
548
0.020
Why?
Immunomagnetic Separation
1
1994
7
0.020
Why?
Radiation Dosage
1
1995
122
0.020
Why?
Growth Inhibitors
1
1994
36
0.020
Why?
Radiation Tolerance
1
1995
89
0.020
Why?
Chromatography, Affinity
1
1994
92
0.020
Why?
HIV
1
1994
83
0.020
Why?
Autoantibodies
1
1994
109
0.020
Why?
Radiotherapy
1
1995
198
0.010
Why?
Ectoderm
1
1992
13
0.010
Why?
Endoderm
1
1992
11
0.010
Why?
RNA Probes
1
1992
23
0.010
Why?
Oogenesis
1
1992
8
0.010
Why?
Larva
1
1992
44
0.010
Why?
Embryo, Nonmammalian
1
1992
47
0.010
Why?
Nucleic Acid Hybridization
1
1992
179
0.010
Why?
Age Factors
1
1995
1152
0.010
Why?
Cytoplasm
1
1992
204
0.010
Why?
Models, Biological
1
1994
1029
0.010
Why?
Amino Acid Sequence
1
1992
1227
0.010
Why?
Saccharomyces cerevisiae
1
1992
370
0.010
Why?
Transcription, Genetic
1
1992
824
0.010
Why?

Visualizations


Liesveld's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department